Compound ID | 316
Class: Beta-lactam
| Agent Type: | Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Streptococcus pneumoniae and Klebsiella pneumoniae; active against pathogens causing respiratory tract infections |
| Institute where first reported: | Korea Inst. Of Sci and Technology; Yonsei Univ. Coll. Of Med; Konkuk Univ. Coll. Of Vet. Med., Korea |
| Year first mentioned: | 2004 |
| Development status: | Experimental |
| External links: |